Bioventus (BVS) FCF Margin (2020 - 2026)
Bioventus' (BVS) quarterly FCF Margin came in at 6.36% in Q1 2026, up 2263.0% YoY from 0.27% in Q1 2025, and down 73.14% on a QoQ basis from 23.68% in Q4 2025.
Bioventus (BVS) FCF Margin (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of FCF Margin data on file, last reported at 6.36% in Q1 2026.
- Quarterly FCF Margin rose 2263.0% year-over-year to 6.36% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.47% (up 1325.0% YoY) and the FY2025 annual result came in at 12.69%, up 610.0% from the prior year.
- FCF Margin eased to 6.36% in Q1 2026, from 23.68% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 23.68% in Q4 2025 to a low of 17.99% in Q2 2022.
- A 5-year average of 4.36% and a median of 7.49% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin slumped 1670 bps — and 2026, when it surged 2263 bps.
- Tracing BVS's FCF Margin over 5 years: stood at 8.43% in 2022, then fell by 9 bps to 7.66% in 2023, then jumped by 57 bps to 11.99% in 2024, then jumped by 97 bps to 23.68% in 2025, then slumped by 73 bps to 6.36% in 2026.
- The last three FCF Margin figures came in at 6.36% (Q1 2026), 23.68% (Q4 2025), and 20.42% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 18.73% |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | 12.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 12.34% |
| Mar 28, 2026 | 6.36% |
| Dec 31, 2025 | 23.68% |
| Sep 27, 2025 | 20.42% |
| Jun 28, 2025 | 17.99% |
| Mar 29, 2025 | -16.27% |
| Dec 31, 2024 | 11.99% |
| Sep 28, 2024 | 7.49% |
| Jun 29, 2024 | 10.08% |
| Mar 30, 2024 | -4.86% |
| Dec 31, 2023 | 7.66% |
| Sep 30, 2023 | -8.96% |
| Jul 1, 2023 | 9.77% |
| Apr 1, 2023 | 0.92% |
| Dec 31, 2022 | 8.43% |
| Oct 1, 2022 | -1.16% |
| Jul 2, 2022 | -1.41% |
| Apr 2, 2022 | -17.99% |
| Dec 31, 2021 | 3.19% |
| Oct 2, 2021 | 6.17% |